Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Recombinant Protein Market Size, Growth, Analysis: By Product Type: Growth Factor and Cytokines, Hormone, Enzyme, Antibody, Immune Checkpoint Proteins, Recombinant Regulatory Proteins; By Application: Therapeutic Use, Others; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2018-2028

Global Recombinant Protein Market Outlook

The global recombinant protein market size reached an estimated value of USD 1.53 billion in 2022. The global market is expected to grow at a CAGR of 12.10% between 2023 and 2028, driven by the increasing demand for effective drugs for chronic diseases.

 

Global Recombinant Protein Market Trends

Recombinant proteins are manipulated forms of proteins that are encoded by recombinant DNA. These proteins are commonly used in the production of pharmaceutical products, enzymes, and antibodies for the development of disease treatments.

 

Producing protein through recombinant DNA technology provides some significant advantages, including the minimized risk of immune reaction and high activity of the protein.

 

  • The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.
     
  • With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.

  • The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.

 

Global Recombinant Protein Market Analysis

Based on product type, the market can be segmented into growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others. Based on application, it can be bifurcated into therapeutic use, research application, and the biotechnology industry. The regional markets for the recombinant protein market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global recombinant protein market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans. 

 

  • Abcam PLC
     
  • Thermo Fisher Scientific, Inc.
     
  • Bio-Techne.
     
  • Merck KGaA
     
  • Bio-Rad Laboratories, Inc.
     
  • GeneTex, Inc
     
  • Others

 

Product Types for Recombinant Proteins in the Market 

Based on product type, the market can be divided into growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others.

 

The hormone segment is expected to hold a significant share of the market owing to its extensive application in research and development for the creation of treatment options for various diseases, such as diabetes.

 

The antibody segment is expected to register a high growth rate due to the increasing focus from key players and healthcare institutes in the development of recombinant antibody products. This procedure allows the antibodies to be produced in large quantities after the selection of antibodies with favourable characteristics.

 

Regional Markets for the Global Recombinant Protein Market

The various regions in the global market include North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The North American region is expected to hold the largest market share owing to the rising number of patients with diseases such as cancer, diabetes, cardiovascular diseases, and chronic respiratory diseases, among many other diseases.

 

The market value in the region is likely to develop further with the increasing investment in research and development by major market players and government agencies, owing to the rising demand for effective medicines and treatment options.

 

Competitive Landscape

Abcam PLC is one of the leaders in the market, engaged in supplying protein research tools to life scientists. The company specializes in identifying, developing, and distributing high-quality biological reagents and tools that are utilized in the healthcare sector for various purposes including research, drug discovery, and diagnostics.

The company is headquartered in Cambridge, United Kingdom, with a focus on developing products such as primary antibodies, secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging tools, among others.

 

Thermo Fisher Scientific, Inc., based in Massachusetts, United States, is one of the world’s largest biotechnology research companies. The company was formed with the merger of Thermo Electron and Fisher Scientific in 2006. The company specialises in various fields including analytical instruments, laboratory supply chain programs and eCommerce, laboratory equipment, lab services, speciality diagnostics, life sciences, pharma services, and CDMO.

 

Bio-Techne. is a biotechnology research company based in Minnesota, United States. The company is a leading developer and manufacturer of purified proteins and reagent solutions. In addition, they are also engaged in providing protein analysis solutions. The company was founded in 1981 and has been operating to develop various products including antibodies, enzymes, proteins, and cell culture reagents, among others. Their focus lies in research fields including cancer, cardiovascular biology, cell and gene therapy, and immunology, among others.

 

Other market players include Merck KGaA, Bio-Rad Laboratories, Inc., and GeneTex, Inc, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • Region
Breakup by Product Type
  • Growth Factor and Cytokines
  • Hormone
  • Enzyme
  • Antibody
  • Immune Checkpoint Proteins
  • Recombinant Regulatory Proteins
  • Others
Breakup by Application
  • Therapeutic Use
  • Research Application
  • Biotechnology Industry
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abcam PLC
  • Thermo Fisher Scientific, Inc.
  • Bio-Techne.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • GeneTex, Inc
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Recombinant Protein Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Recombinant Protein Historical Market (2018-2022) 
    8.3    Global Recombinant Protein Market Forecast (2023-2028)
    8.4    Global Recombinant Protein Market by Product Type
        8.4.1    Growth Factor and Cytokines
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Hormone
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Enzyme
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Antibody
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
        8.4.5    Immune Checkpoint Proteins
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2018-2022)
            8.4.5.3    Forecast Trend (2023-2028)
        8.4.6    Recombinant Regulatory Proteins
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2018-2022)
            8.4.6.3    Forecast Trend (2023-2028)
        8.4.7    Others
    8.5    Global Recombinant Protein Market by Application
        8.5.1    Therapeutic Use
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Research Application
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Biotechnology Industry
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
    8.6    Global Recombinant Protein Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022) 
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022) 
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022) 
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022) 
            8.6.4.3    Forecast Trend (2023-2028)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022) 
            8.6.5.3    Forecast Trend (2023-2028)
9    North America Recombinant Protein Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Recombinant Protein Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Recombinant Protein Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Recombinant Protein Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Recombinant Protein Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Abcam PLC
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Thermo Fisher Scientific, Inc.
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Bio-Techne.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Merck KGaA
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Bio-Rad Laboratories, Inc.
            16.2.5.1    Company Overview
            16.2.5.2    Product Portfolio
            16.2.5.3    Demographic Reach and Achievements
            16.2.5.4    Certifications
        16.2.6    GeneTex, Inc
            16.2.6.1    Company Overview
            16.2.6.2    Product Portfolio
            16.2.6.3    Demographic Reach and Achievements
            16.2.6.4    Certifications
        16.2.7    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Recombinant Protein Market: Key Industry Highlights, 2018 and 2028
2.    Global Recombinant Protein Historical Market: Breakup by Product Type (USD Billion), 2018-2022
3.    Global Recombinant Protein Market Forecast: Breakup by Product Type (USD Billion), 2023-2028
4.    Global Recombinant Protein Historical Market: Breakup by Application (USD Billion), 2018-2022
5.    Global Recombinant Protein Market Forecast: Breakup by Application (USD Billion), 2023-2028
6.    Global Recombinant Protein Historical Market: Breakup by Region (USD Billion), 2018-2022
7.    Global Recombinant Protein Market Forecast: Breakup by Region (USD Billion), 2023-2028
8.    North America Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2022
9.    North America Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2023-2028
10.    Europe Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2022
11.    Europe Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2023-2028
12.    Asia Pacific Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2022
13.    Asia Pacific Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2023-2028
14.    Latin America Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    Latin America Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Middle East and Africa Recombinant Protein Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Middle East and Africa Recombinant Protein Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Global Recombinant Protein Market Structure

Key Questions Answered in the Report

The global market size for recombinant protein reached an approximate size of USD 1.53 billion in 2022.

The market is expected to grow at a CAGR of around 12.10% during the forecast period of 2023-2028.

The market growth is driven by the growing demand for recombinant protein drugs for the treatment of chronic diseases and the increasing demand for such drugs due to the rising prevalence of diseases such as diabetes and cancer, among others.

The increasing investments by government agencies and key players for the development of new and effective medicine are expected to offer new growth opportunities to the market.

The regional markets for the recombinant protein include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The products available in the market include growth factor and cytokines, hormone, enzyme, antibody, immune checkpoint proteins, and recombinant regulatory proteins, among others.

The recombinant protein technology is applied in therapeutic use, research application, and the biotechnology industry.

The key players in the market include Abcam PLC, Thermo Fisher Scientific, Inc., Bio-Techne., Merck KGaA, Bio-Rad Laboratories, Inc., and GeneTex, Inc, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER